Positive Patch Test Reactions to Carba Mix and Thiuram Mix: The North American Contact Dermatitis Group Experience (1994-2016)

被引:12
作者
Warshaw, Erin M. [1 ,2 ,3 ]
Gupta, Rachit [1 ,3 ,4 ]
Silverberg, Jonathan, I [5 ]
Maibach, Howard, I [6 ]
DeKoven, Joel G. [7 ]
Taylor, James S. [8 ]
Atwater, Amber R. [9 ]
Reeder, Margo J. [10 ]
Zug, Kathryn A. [11 ]
Sasseville, Denis [12 ]
Fowler, Joseph F., Jr. [13 ]
Pratt, Melanie D. [14 ]
Fransway, Anthony F. [15 ]
Belsito, Donald, V [16 ]
DeLeo, Vincent A. [17 ]
机构
[1] Pk Nicollet Hlth Serv, Dept Dermatol, St Louis Pk, MN USA
[2] Univ Minnesota, Dept Dermatol, Minneapolis, MN 55455 USA
[3] Minneapolis Vet Affairs Med Ctr, Dept Dermatol, Minneapolis, MN USA
[4] Univ Minnesota, Med Sch, Minneapolis, MN USA
[5] George Washington Univ, Dept Dermatol, Sch Med & Hlth Sci, Washington, DC USA
[6] Univ Calif San Francisco, Dept Dermatol, San Francisco, CA USA
[7] Univ Toronto, Sunnybrook Hlth Sci Ctr, Div Dermatol, Toronto, ON, Canada
[8] Cleveland Clin, Dept Dermatol, Cleveland, OH USA
[9] Duke Univ, Dept Dermatol, Med Ctr, Durham, NC USA
[10] Univ Wisconsin, Dept Dermatol, Sch Med & Publ Hlth, Madison, WI USA
[11] Dartmouth Hitchcock Med Ctr, Dept Dermatol, Lebanon, NH USA
[12] McGill Univ, Montreal Gen Hosp, Div Dermatol, Quebec City, PQ, Canada
[13] Univ Louisville, Div Dermatol, Louisville, KY USA
[14] Univ Ottawa, Div Dermatol, Ottawa, ON, Canada
[15] Associates Dermatol, Ft Myers, FL USA
[16] Columbia Univ, Dept Dermatol, New York, NY 10027 USA
[17] Keck Sch Med, Dept Dermatol, Los Angeles, CA USA
关键词
ALOPECIA-AREATA; INHIBITOR RUXOLITINIB; TOPICAL RUXOLITINIB; JAK1/2; INHIBITOR; PATIENT; VASCULOPATHY; UNIVERSALIS; VITILIGO; EFFICACY;
D O I
10.1097/DER.0000000000000648
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background/Objective: This study characterizes concomitant reactions to carbamix (CM) and thiuram mix (TM) in a large North American population. Because thiurams and dithiocarbamates have structural similarity, concomitant reactions are expected. Methods: The 1994-2016 North American Contact Dermatitis Group data were analyzed. Patients with a final reaction interpreted as "allergic" to either CM or TM were included. Results: A total of 49,758 patients were tested to both CM and TM. A total of 3437 (6.9%) had positive reactions to CM and/or TM including the following groups: CM+ only (n = 1403, 40.8%), TM+ only (n = 1068, 31.0%), or both (n = 966, 28.1%). A total of 47.5% of TM+ patients were positive to CM and 40.8% of CM+ patients were positive to TM. Male sex, occupationally related dermatitis, and hand involvement were significantly more common in individuals positive to CM and/or TM as compared with those who were negative (P < 0.0001). More than 80% of CM+/TM+ reactions were currently relevant. Gloves were the most common source of CM and TM; clothing and footwear were also frequent. Conclusions: Carba mix and TM remain important, clinically relevant allergens. Although significant concomitant reaction frequency was demonstrated, more than half of the patients reacting to either CM or TM would have been missed if both had not been tested, underscoring the importance of testing to both.
引用
收藏
页码:173 / 184
页数:12
相关论文
共 64 条
[1]  
Aboul-Fettouh Nader, 2018, JAAD Case Rep, V4, P455, DOI 10.1016/j.jdcr.2018.01.001
[2]   A child with severe juvenile dermatomyositis treated with ruxolitinib [J].
Aeschlimann, Florence A. ;
Fremond, Marie-Louise ;
Duffy, Darragh ;
Rice, Gillian I. ;
Charuel, Jean-Luc ;
Bondet, Vincent ;
Saire, Elsa ;
Neven, Benedicte ;
Bodemer, Christine ;
Balu, Laurent ;
Gitiaux, Cyril ;
Crow, Yanick J. ;
Bader-Meunier, Brigitte .
BRAIN, 2018, 141
[3]   Janus Kinase Inhibitors for the Treatment of Severe Alopecia Areata: An Open-Label Comparative Study [J].
Almutairi, Nawaf ;
Nour, Tarek M. ;
Hussain, Nasser Haji .
DERMATOLOGY, 2019, 235 (02) :130-136
[4]   JAK Inhibitor Therapy in a Child with Inherited USP18 Deficiency [J].
Alsohime, Fahad ;
Martin-Fernandez, Marta ;
Temsah, Mohamad-Hani ;
Alabdulhafid, Majed ;
Le Voyer, Tom ;
Alghamdi, Malak ;
Qiu, Xueer ;
Alotaibi, Najla ;
Alkahtani, Areej ;
Buta, Sofija ;
Jouanguy, Emmanuelle ;
Al-Eyadhy, Ayman ;
Gruber, Conor ;
Hasan, Gamal M. ;
Bashiri, Fahad A. ;
Halwani, Rabih ;
Hassan, Hamdy H. ;
Al-Muhsen, Saleh ;
Alkhamis, Nouf ;
Alsum, Zobaida ;
Casanova, Jean-Laurent ;
Bustamante, Jacinta ;
Bogunovic, Dusan ;
Alangari, Abdullah A. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (03) :256-265
[5]  
[Anonymous], EndNote X8.2. 2014
[6]  
[Anonymous], 2020, JAK RUX PACK INS
[7]   Baricitinib experience on STING-associated vasculopathy with onset in infancy: A representative case from Turkey [J].
Balci, Sibel ;
Ekinci, Rabia Miray Kisla ;
de Jesus, Adriana Almeida ;
Goldbach-Mansky, Raphaela ;
Yilmaz, Mustafa .
CLINICAL IMMUNOLOGY, 2020, 212 :113-116
[8]   Topical Janus kinase inhibitors for the treatment of pediatric alopecia areata [J].
Bayart, Cheryl B. ;
DeNiro, Katherine L. ;
Brichta, Lars ;
Craiglow, Brittany G. ;
Sidbury, Robert .
JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 77 (01) :167-170
[9]   Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation [J].
Bloomfield, Marketa ;
Kanderova, Veronika ;
Parackova, Zuzana ;
Vrabcova, Petra ;
Svaton, Michael ;
Fronkova, Eva ;
Fejtkova, Martina ;
Zachova, Radana ;
Rataj, Michal ;
Zentsova, Irena ;
Milota, Tomas ;
Klocperk, Adam ;
Kalina, Tomas ;
Sediva, Anna .
JOURNAL OF CLINICAL IMMUNOLOGY, 2018, 38 (05) :589-601
[10]   Treatment of alopecia universalis with topical Janus kinase inhibitors - a double blind, placebo, and active controlled pilot study [J].
Bokhari, Laita ;
Sinclair, Rodney .
INTERNATIONAL JOURNAL OF DERMATOLOGY, 2018, 57 (12) :1464-1470